Home›Stock Screener›Sanofi Consumer Healthcare›Financial Statements

Sanofi Consumer Healthcare Complete Financial Statements

2 Years of Data
2024 - 2023

In FY2024, Sanofi Consumer Healthcare (SANOFICONR) reported revenue ₹738 Cr, net profit ₹181 Cr and EPS ₹78.59, with a net profit margin of 24.5% and ROE of 66.3%. Full financial statements from FY2023 to FY2024 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see SANOFICONR stock price BSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 24.53% 2024 data
EBITDA Margin 38.48% 2024 data
Operating Margin 37.00% 2024 data
Return on Assets 42.00% 2024 data
Return on Equity 66.30% 2024 data

Balance Sheet Ratios

Current Ratio 14.00 2024 data
Equity Ratio 63.34% 2024 data
Asset Turnover 1.71 2024 data

SANOFICONR Revenue, Net Profit & EBITDA — Year-on-Year Growth

SANOFICONR YoY (March 2023 vs March 2024) — revenue +31.8%, net profit +9.7%, EBITDA +27.4%, expenses +34.7%. See SANOFICONR book value to compare market price against book value per share.

Revenue Growth
+31.8%
Year-over-Year
Net Profit Growth
+9.7%
Year-over-Year
EBITDA Growth
+27.4%
Year-over-Year
Expense Growth
+34.7%
Year-over-Year
Assets Growth
+24.9%
Year-over-Year
Equity Growth
+31.3%
Year-over-Year
Financing Cash Flow Growth
-5900.0%
Year-over-Year

SANOFICONR Income Statement — Revenue, EBITDA & Net Profit

Sanofi Consumer Healthcare revenue ₹738 Cr, EBITDA ₹284 Cr, net profit ₹181 Cr, EPS ₹78.59 (2024) — net profit margin 24.5%. Check SANOFICONR market capitalization to track the company's total market size over time.

Periods ₹ Crores
Particulars March 2024 March 2023
Revenue 738 560
Expenses 454 337
EBITDA 284 223
Operating Profit Margin % 37.00% 39.00%
Depreciation 5 2
Interest 4 0
Profit Before Tax 247 219
Tax 66 54
Net Profit 181 165
Earnings Per Share (₹) 78.59 71.60

SANOFICONR Balance Sheet — Assets, Liabilities & Shareholders' Equity

SANOFICONR total assets ₹431 Cr, total equity ₹273 Cr, total liabilities ₹ Cr (2024) — ROE 66.3%.

Years Annual Data ₹ Crores
Particulars 2024 2023
ASSETS
Total Assets 431 345
Current Assets 392 335
Fixed Assets 29 5
Capital Work in Progress 1 3
Investments 0 0
Other Assets 402 338
LIABILITIES
Total Liabilities
Current Liabilities 28 8
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 273 208
Share Capital 23 2
Reserves & Surplus 250 183

SANOFICONR Cash Flow Statement — Operating, Investing & Financing

Sanofi Consumer Healthcare operating cash flow ₹439 Cr, investing ₹2 Cr, financing ₹-116 Cr, net cash flow ₹325 Cr (2024).

Periods ₹ Crores
Particulars March 2024 March 2023
Operating Activities 439 0
Investing Activities 2 0
Financing Activities -116 2
Net Cash Flow 325 2